Related Experiment Video
Updated: Feb 18, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
The Actionability of Exome sequencing testing results
Tanya Stivers1, Stefan Timmermans
1Department of Sociology, UCLA, USA.
Genomic sequencing offers valuable insights beyond direct medical management. For families of children with disabilities, exome sequencing results help address parental guilt and access essential services.
Area of Science:
- Genomics
- Clinical Genetics
- Medical Sociology
Background:
- Genomic tests like exome sequencing are increasingly available for patient diagnosis.
- The clinical utility of extensive genetic information is under examination.
- Professional organizations advocate for broader definitions of genomic sequencing benefits.
Purpose of the Study:
- To investigate how genomic test results become actionable in clinical encounters.
- To explore the utility of exome sequencing beyond traditional diagnostic and management goals.
- To understand the parental experience of receiving exome sequencing results for children with disabilities.
Main Methods:
- Video-recorded observations of exome sequencing result returns in a clinical setting.
- In-depth interviews with parents of children with disabilities.
- Qualitative analysis of clinical encounters and parental perspectives.
Main Results:
- Exome results are utilized by parents and clinicians for purposes beyond biomedical diagnosis and management.
- Genomic information is marshaled to address parental guilt related to a child's disability.
- Test results facilitate access to disability-related services for families.
Conclusions:
- Genomic actionability is influenced by the interplay between genetic findings and parental circumstances.
- The clinical utility of exome sequencing extends to psychosocial and practical support for families.
- A broader perspective is needed to fully appreciate the benefits of genomic testing in diverse patient populations.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016